Results 181 to 190 of about 6,070,327 (323)
ABSTRACT Advancements in tissue engineering have revolutionized therapeutic paradigms for diabetic tissue defects; however, the lack of applicable scaffold containing various bioactive substance aggregates remained a critical bottleneck hindering satisfactory repair effect.
Tao Wang +8 more
wiley +1 more source
Choroidal ischemia after self-injection of hyaluronic acid filler. [PDF]
Duncan NB, Reed D, Harper CA, Nakra T.
europepmc +1 more source
The cascade supramolecular assembly of charge‐transfer arrays not only triggered a topological transformation from nanofiber to nanorod and vesicles, but also promoted single‐molecule phosphorescent resonance energy transfer, expanding phosphorescence emission at 500 nm to near‐infrared delayed fluorescence emission at 650 nm with a lifetime of 11.20 ...
Zhuo Lei +5 more
wiley +1 more source
Dissolving Hyaluronic Acid Filler: The Diffusion Barrier to Hyaluronidase Efficacy. [PDF]
Murray G, Khoshnaw S, Velthuis P.
europepmc +1 more source
Peptide dendrimer–based nanoplatform with mitochondria‐targeting capability was developed for synergistic chemo‐photothermal therapy. The system promotes efficient transcytosis, induces mitochondrial dysfunction, triggers immunogenic cell death (ICD), and enhance antitumor immunity by promoting dendritic cell maturation and T‐cell activation, resulting
Min Li +15 more
wiley +1 more source
Dilute Hyaluronic Acid for Lipoatrophy: Three Cases and Literature Review. [PDF]
O'Reilly JM +3 more
europepmc +1 more source
In this study, a MXene‐based V4C3 nanoplatform, VARH, was constructed, which achieved a photothermal conversion efficiency of 44.21% in the NIR‐II window. This platform integrated photothermal therapy, chemodynamic therapy, and thermodynamic therapy with CRISPR/Cas9‐mediated heat shock protein 90 knock‐out technology.
Zi‐Jian Huang +8 more
wiley +1 more source
Long-Term Persistence of Hyaluronic Acid Fillers: A Clinical Illustration and Implications for Practice. [PDF]
Prager M, Lusher J.
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Hyaluronic acid degradation by Purpureocillium lilacinum: biochemical and transcriptomic insights. [PDF]
Minguet-Lobato M +4 more
europepmc +1 more source

